A multicenter characterization of hepatitis associated with immune checkpoint inhibitors.
Patrinely JR Jr, McGuigan B, Chandra S, Fenton SE, Chowdhary A, Kennedy LB, Mooradian MJ, Palmeri M, Portal D, Horst SN, Scoville EA, Long GV, Shi C, Mehnert JM, Sullivan RJ, Salama AK, Sosman JA, Menzies AM, Johnson DB.
Patrinely JR Jr, et al.
Oncoimmunology. 2021 Feb 8;10(1):1875639. doi: 10.1080/2162402X.2021.1875639.
Oncoimmunology. 2021.
PMID: 33628621
Free PMC article.